Investing.com -- In a Monday report, funding financial institution Raymond James delved into potential coverage actions that might affect the…
Soccer matches might be exhilaratingly unpredictable, but just a few key elements typically decide who walks away with the win.…
On Friday, Needham reaffirmed its constructive stance on Viridian Therapeutics (NASDAQ:VRDN), sustaining a Purchase ranking and a $30.00 worth goal.…
Our selection of the week's biggest research news and features sent directly to your inbox. Enter your email address, confirm you're happy to receive our emails.
Please contact salesdepartment
for further information at:
Sales@88.broker
Sign in to your account